Lichen China
LICN
4 hedge funds and large institutions have $57.6K invested in Lichen China in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
176% more capital inflows, than outflows
Capital inflows: $28.8K | Capital outflows: $10.4K
33% more funds holding
Funds holding: 3 → 4 (+1)
0.07% more ownership
Funds ownership: 0.26% → 0.32% (+0.07%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$24.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$10.4K |
LICN Hedge Fund Activity: Q2 2023 in Review
4 of the 6,389 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q2 2023, worth a combined $57.6K — down 21% from $72.7K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LICN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $24.6K. The largest seller was Two Sigma Investments, cutting an estimated $10.4K.
- 4 institutional investors held Lichen China (LICN) as of Q2 2023, up from 3 in Q1 2023.
- Funds reported $57.6K of Lichen China stock for Q2 2023, down 21% quarter-over-quarter.
- 1 fund opened new Lichen China positions in Q2 2023 and 0 closed out, a net change of +1 holder.
- The largest Lichen China buyer in Q2 2023 was Renaissance Technologies, an estimated $24.6K added.
- The largest Lichen China seller in Q2 2023 was Two Sigma Investments, an estimated $10.4K sold.
Based on aggregated 13F filings for Q2 2023.